References
Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med. 1996:334:1011–7.
Danner SA, Carr A, Leonard JM, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med. 1995:333:1528–33.
Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997:337:734–9.
Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 cubic millimeter or less. N Engl J Med. 1997:337:725–33.
Torres RA, Barr M. Impact of combination therapy for HIV infection on inpatient census. N Engl J Med. 1997:336:1531–2. Letter.
Hogg RS, O’Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet. 1997:349:1294. Letter.
Update. Trends in AIDS incidence—United States, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:861–7. Report, June 12, 1997:45 (suppl 2).
Singer PA, Thiel EC, Salit I, Flanagan W, Naylor CD. The HIV-specific advance directive. J Gen Intern Med 1997:12:729–34.
Wolf SM, Boyle P, Callahan D, et al. Sources of concern about the Patient Self-Determination Act. N Engl J Med. 1991;325:1666–71.
Brett AS. Limitations of listing specific medical interventions in advance directives [see comments]. JAMA. 1991;266:825–8.
Starr TJ, Pearlman RA, Uhlmann RF. Quality of life and resuscitation decisions in elderly patients. J Gen Intern Med 1986;1:373–9.
Bedell SE, Delbanco TL. Choices about cardiopulmonary resuscitation in the hospital: when do physicians talk with patients? N Engl J Med. 1984;310:1089–93.
Seckler AB, Meier DE, Mulvihill M, Cammer BE. Substituted judgment: how accurate are proxy predictions? Ann Intern Med. 1991; 115:92–8.
Uhlmann RF, Pearlman RA. Perceived quality of life and preferences for life-sustaining treatment in older adults. Arch Intern Med. 1991;151:495–7.
Uhlmann RF, Pearlman RA, Cain KC. Understanding of elderly patients’ resuscitation preferences by physicians and nurses. West J Med 1989;150:705–7.
Zweibel NR, Cassel CK. Treatment choices at the end of life: a comparison of decisions by older patients and their physicianselected proxies. Gerontology 1989;29:615–21.
Uhlmann RF, Pearlman RA, Cain KC. Physicians’ and spouses’ predictions of elderly patients’ resuscitation preferences. J Gerontol. 1988;43:M115–21.
Ouslander JG, Tymchuk AJ, Rahbar B. Health care decisions among elderly long-term care residents and their potential proxies. Arch Intern Med 1989;149:1367–72.
Wilson IB, Green ML, Goldman L, Tsevat J, Cook EF, Phillips RS. Is experience a good teacher? How interns and attending physicians understand patients’ choices for end-of-life care. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Med Decis Making 1997; 17:217–27.
Hanson LC, Tulsky JA, Danis M. Can clinical interventions change care at the end of life? Ann Intern Med 1997;126:381–8.
The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). JAMA 1995;274:1591–8.
Curtis JR, Patrick DL. Barriers to patient-physician communication about end-of-life care: a qualitative study of patients with AIDS and physicians with AIDS experience. J Gen Intern Med. 1997;12:736–41.
Emanuel LL. Structured deliberation to improve decisionmaking for the seriously ill Hastings Cent Rep 1995;25:S14–8.
Forrow L. The green eggs and ham phenomena. Hastings Cent Rep 1997;24:S29–32.
Callahan D. Once again, reality. Now where do we go? Hastings Cent Rep. 1995;25:S33–6.
Hofmann JC, Wenger NS, Davis RB, et al. Patient preferences for communication with physicians about end-of-life decisions. Ann Intern Med 1997;127:1–12.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilson, I.B. End-of-life care in HIV disease. J GEN INTERN MED 12, 784–786 (1997). https://doi.org/10.1046/j.1525-1497.1997.07166.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.1997.07166.x